Abstract
Medullary Thyroid cancer is a rare malignancy with aggressive behaviour, which can be either sporadic or hereditary. Diagnosis is based on measuring the serum calcitonin levels of patients with thyroid nodules or on screening for RET gene mutations of the first degree relatives of patients with hereditary MTC. Treatment is surgical and involves total thyroidectomy and central lymph node dissection in all diagnosed cases. Further lateral LN dissection should be performed when indicated and is further analyzed throughout the article. Postoperative observation includes biochemical markers of disease (calcitonin and CEA) as well as imaging studies when indicated. Recurrence rates are high because of early lymphatic metastases. However, the overall 5-year survival rates are also high.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
